Regulations

The conference will be held on-site at the Faculty of Pharmacy of Lithuanian University of Health Sciences, Sukileliu Ave. 13, Kaunas, LT-50166, Lithuania.

All participants are required to attend the conference on-site. No exceptions apply for international participants.

In case of illness or unplanned emergencies, the Organising Committee must be informed immediately. For emergency contact information, please email: info@ihsc.eu.

For LSMU SMD members*, the submission fee for the first abstract is 25 EUR (this price applies only if the submitter is an LSMU SMD member), and for non-members – 40 EUR. When submitting more than one abstract, a fee of 40 EUR is charged for each additional abstract (including LSMU SMD members).

Passive participants who wish to receive a welcome pack and certificate of attendance must pay a 10 EUR fee.

Additionally, both active and passive participants will be required to pay a 5–15 EUR fee per workshop.

Refund policy. All fees (active participant, passive participant and workshop fees) are non-refundable, including in cases where the participant is unable to attend the conference.

The fee category is determined automatically by the account used to log in to the submission system. LSMU SMD members must log in with their LSMU SMD account before making the payment in order to be charged the member price. If a payment is made using a different account or under the non-member category, the price difference will not be refunded. The Organising Committee is not responsible for payments made in an incorrect category, through an incorrect account or with incorrect personal data entered by the participant.

All submitters whose abstracts are rejected by the Reviewers are welcome to attend as passive participants at no additional cost.

*Those who have already paid the LSMU SMD fee for the 2026–2027 academic year.

E.g. if you are an active participant (presenter) and would like to attend 1 workshop, you need to pay 25 EUR as the submission fee when submitting the abstract, and 10 EUR for 1 workshop. If you are a passive participant and would like to attend 2 workshops, you must pay 10 EUR for passive participation and 20 EUR for 2 workshops.

Payments are accepted only through the submission system. We do not accept bank transfers or other payment methods. Before paying, please check that you are logged in with the correct account and that the price shown corresponds to your participant category. Payments cannot be refunded or transferred.

When submitting an abstract, every participant must select a session and a specific topic within that session. The detailed list of sessions and topics is provided below. If none of the topics fits the work, select “Other” within the most relevant session. The list of sessions and topics is preliminary and may be subject to change after the abstract submission deadline.

Case reports

• Internal medicine

• Cardiology

• Surgery

• Paediatrics & neonatology

• Obstetrics & gynaecology

• Neurology, neurosurgery & psychiatry

• Oncology & haematology

• Infectious diseases

• Anaesthesiology, intensive care & emergency medicine

• Dermatology

• Other clinical fields

Anaesthesiology & Intensive therapy, Emergency medicine

• General & regional anaesthesia

• Perioperative medicine & pain management

• Airway management

• Sepsis & septic shock

• Mechanical ventilation & acute respiratory failure

• Cardiopulmonary resuscitation

• Trauma & prehospital emergency care

• Clinical toxicology & poisoning

• Disaster & mass-casualty medicine

• Other

Basic sciences & Pharmacology

• Anatomy & histology

• Physiology & pathophysiology

• Biochemistry & molecular biology

• Genetics & genomics

• Cell biology & stem cells

• Microbiology & immunology

• Pathology

• Pharmacology & clinical pharmacy

• Pharmaceutical sciences & drug development

• Experimental & animal models

• Other

Cardiology

• Coronary artery disease & acute coronary syndromes

• Heart failure & cardiomyopathies

• Arrhythmias & electrophysiology

• Arterial hypertension

• Valvular heart disease

• Congenital heart disease

• Cardiovascular imaging

• Preventive cardiology & cardiovascular risk factors

• Pulmonary hypertension & venous thromboembolism

• Interventional cardiology

• Other

Dermatovenerology

• Inflammatory skin diseases (psoriasis, atopic dermatitis, etc.)

• Skin cancer & melanoma

• Autoimmune & bullous skin diseases

• Infectious skin diseases

• Sexually transmitted infections

• Hair & nail disorders

• Dermatoscopy & skin imaging

• Dermatosurgery & aesthetic dermatology

• Other

Internal medicine

• Gastroenterology & hepatology

• Pulmonology

• Endocrinology, diabetes & metabolism

• Rheumatology & clinical immunology

• Nephrology

• Infectious diseases

• Haematology (non-malignant)

• Allergology

• Geriatrics

• Clinical nutrition

• Other

Neurosciences

• Stroke & cerebrovascular diseases

• Epilepsy

• Neurodegenerative & movement disorders

• Multiple sclerosis & neuroimmunology

• Headache & pain

• Neuromuscular diseases

• Neurosurgery (neuro-oncology, spine, neurotrauma)

• Mood & anxiety disorders

• Psychotic disorders

• Addiction medicine

• Child & adolescent psychiatry, neurodevelopmental disorders

• Other

Nursing

• Clinical nursing practice

• Patient safety & quality of care

• Nursing education

• Community & home care

• Palliative & end-of-life care

• Geriatric nursing

• Nursing management & leadership

• Digital health in nursing

• Other

Obstetrics & Gynaecology

• Pregnancy & maternal-fetal medicine

• Labour & delivery, midwifery

• Reproductive medicine & infertility

• Gynaecological oncology

• Benign gynaecology & endometriosis

• Urogynaecology

• Contraception & sexual health

• Menopause

• Other

Odontology & Maxillofacial surgery

• Restorative dentistry & endodontics

• Periodontology

• Prosthodontics

• Orthodontics

• Paediatric dentistry

• Oral surgery & implantology

• Oral medicine & oral pathology

• Maxillofacial surgery & trauma

• Dental materials & digital dentistry

• Other

Oncology

• Cancer epidemiology, prevention & screening

• Cancer biology & biomarkers

• Systemic therapy (chemotherapy, immunotherapy, targeted therapy)

• Radiation oncology

• Surgical oncology

• Haemato-oncology

• Paediatric oncology

• Supportive & palliative care in oncology

• Other

Ophthalmology

• Cataract & refractive surgery

• Glaucoma

• Retina & vitreous (incl. diabetic retinopathy, AMD)

• Cornea & ocular surface

• Paediatric ophthalmology & strabismus

• Neuro-ophthalmology

• Oculoplastic surgery

• Ocular imaging & artificial intelligence

• Other

Otorhinolaryngology

• Otology & hearing

• Audiology & vestibular disorders

• Rhinology & sinus diseases

• Laryngology & voice disorders

• Head & neck oncology

• Paediatric otorhinolaryngology

• Sleep-disordered breathing

• Facial plastic surgery

• Other

Paediatrics

• Neonatology

• General paediatrics, growth & development

• Paediatric infectious diseases & vaccination

• Paediatric cardiology

• Paediatric gastroenterology & nutrition

• Paediatric endocrinology

• Paediatric neurology

• Paediatric pulmonology & allergology

• Paediatric emergency & intensive care

• Adolescent medicine

• Other

Posters

Abstracts from all fields; authors select the topic from the session lists above

Public Health

• Epidemiology

• Health promotion & disease prevention

• Environmental & occupational health

• Health policy & health care management

• Global health

• Lifestyle & health behaviour (nutrition, physical activity, tobacco, alcohol)

• Population mental health

• Digital health & health informatics

• Medical & health professions education

• Other

Radiology

• Neuroradiology

• Thoracic & cardiovascular imaging

• Abdominal imaging

• Musculoskeletal imaging

• Breast imaging

• Paediatric radiology

• Interventional radiology

• Nuclear medicine & molecular imaging

• Artificial intelligence & radiomics

• Other

Rehabilitation

• Neurological rehabilitation

• Musculoskeletal & orthopaedic rehabilitation

• Cardiopulmonary rehabilitation

• Physiotherapy

• Occupational therapy

• Speech & language therapy

• Paediatric rehabilitation

• Geriatric rehabilitation

• Assistive technologies

• Other

Sports medicine & kinesiology

• Exercise physiology

• Sports injuries & injury prevention

• Physical activity & health

• Sports cardiology

• Biomechanics & motor control

• Sports nutrition

• Training & athletic performance

• Adapted physical activity

• Other

Surgery I: General surgery

• Upper gastrointestinal surgery

• Hepatobiliary & pancreatic surgery

• Colorectal surgery

• Hernia & abdominal wall surgery

• Endocrine surgery

• Breast surgery

• Bariatric & metabolic surgery

• Minimally invasive & robotic surgery

• Emergency surgery & trauma

• Other

Surgery II: Specialised surgery

• Cardiac surgery

• Thoracic surgery

• Vascular surgery

• Orthopaedics & traumatology

• Paediatric surgery

• Urology

• Plastic & reconstructive surgery

• Transplant surgery

• Other

The final allocation of abstracts to sessions depends on the number of accepted abstracts. If a session has fewer than 7 or more than 12 accepted abstracts, the IHSC 2027 Organising Committee reserves the right to transfer abstracts to a different session, combine sessions or divide a session. The Organising Committee also reserves the right to transfer an abstract to another session if its topic is deemed more relevant to that session.

• Submitter – the person who submits the abstract in the submission system and is responsible for the information provided, the payment and communication with the Organising Committee.

• Presenting author (presenter) – the author who presents the work at the conference. The presenter must be a bachelor’s or master’s degree student, is registered as an active participant and receives a certificate of oral or poster presentation.

• Co-authors – all other authors who contributed to the work. Co-authors are listed in the Abstract book but do not present. Co-authors who wish to attend the conference must purchase a passive participant ticket.

• Scientific supervisor – the academic supervisor of the work, listed among the authors.

The order of authors entered in the submission system will be used in the Abstract book and on certificates.

Active participants (presenters)

The submitter has to designate a presenter at the time of submitting the abstract. The submitter may change the designated presenter after submission, provided that the new presenter is one of the co-authors listed in the abstract and meets the eligibility criteria (bachelor’s or master’s degree student). Changes can be made until a date to be announced by contacting info@ihsc.eu. The list of authors and their order cannot be changed after the submission deadline. The designated presenter will be considered an active participant responsible for delivering the presentation. If the co-authors want to attend the conference, they have to obtain a passive participant’s ticket.

Abstracts must be uploaded to the IHSC 2027 submission system: submit.ihsc.eu. Submission is open only to university students who are pursuing a bachelor’s or master’s degree from any accredited higher education institution. One active participant can submit only one case report abstract and an unlimited number of original research abstracts in all topics.

Each abstract must be submitted separately. Submission dates: 2nd of November 2026 – 22nd of December 2026, 23:59 EET. No abstracts submitted outside these dates will be accepted.

The submission fee is paid via the submission system when submitting the abstract (see “Fees” and “Payment instructions”). Participation fees are non-refundable.

Passive participants

If you do not submit an abstract to IHSC 2027, you can still participate in the conference as a passive participant. Passive participants must pay a 10 EUR participation fee and are eligible for a certificate of attendance and a welcome pack.

All submitters whose abstracts are rejected by the Reviewers are welcome to attend as passive participants at no additional cost.

Attendance at the conference is necessary to receive a certificate and a welcome pack. Tickets will be available at ihsc.eu/tickets; ticket sale dates are to be announced. Workshops are not included in the participation fee. Participation fees are non-refundable.

Workshops

To attend workshops, all participants must pay a 5–15 EUR fee per workshop. Tickets to each workshop are sold separately at ihsc.eu/tickets; ticket sale dates are to be announced.

It is possible to attend a workshop without being registered as an active or passive participant. Attendance at the workshops is necessary to receive a certificate. Participation fees are non-refundable unless the workshop is cancelled by the Organising Committee.

Active participants

• Abstract submission: 2nd of November 2026 – 22nd of December 2026, 23:59 EET.

• Review: 4th – 25th of January 2027, 23:59 EET. Each abstract is reviewed independently by 2 or 3 Reviewers. There will be no abstract correction or secondary review.

• Final Reviewers’ decision (accepted or rejected), session allocation, the format of the presentation (oral or poster) and templates (available in the submission system): 25th of January – 5th of February 2027, 23:59 EET.

• Revision of accepted abstracts according to the Reviewers’ comments (optional): to be announced.

• Oral presentations and posters must be uploaded to the online MS Forms sent by the Organising Committee: to be announced.

• Conference: 4–5 March 2027.

• Abstract book and certificates: to be announced.

Passive participants and workshops

• Tickets will be available at ihsc.eu/tickets: to be announced.

All certificates will be issued in online PDF format. All certificates and the Abstract book will be issued by a date to be announced.

On-site attendance of the conference is necessary in order to receive a certificate and a welcome pack. Certificates are issued only to active and passive participants. Certificates for attending workshops are also issued.

Key information

• Case reports and original research are accepted at the conference. Literature reviews (including systematic review and meta-analysis review) are NOT accepted.

• Abstracts must be written in English.

• One submitter can submit only one case report abstract and an unlimited number of original research abstracts in all topics. Each abstract must be submitted separately.

• Abstracts can be submitted from 2nd of November 2026 until 22nd of December 2026, 23:59 EET. No abstracts submitted outside these dates will be accepted.

• A submission fee is paid when submitting the abstract (see “Fees”).

• When submitting an abstract, authors must select a session and a specific topic (see “Sessions”).

• The best work in each session will be awarded.

• Abstracts must not have been published in any format before submitting the abstract (e.g., the Abstract book).

• All submissions must adhere to ethical guidelines, including proper citation and acknowledgment of prior work, ensuring no form of plagiarism or unethical research practices.

Original research

An original research abstract involves the collection and analysis of data to answer a specific research question or hypothesis. This type of research is designed to generate new knowledge, provide insight into existing knowledge, or test a theory by conducting a structured study.

Presented research should involve collecting and analysing novel data through experiments, surveys, or other methods. Please note that secondary reviews or summaries of existing research do not qualify as original research. Extensive guidelines for reporting can be found on equator-network.org.

Terms for registering and accepting abstracts

• Abstracts must be written in English.

• A submitter can submit an unlimited number of original research abstracts in all topics.

• Abstracts can be submitted for oral or poster presentation. Authors are asked for their preference. However, the final presentation format will be assigned by IHSC 2027 Reviewers based on the evaluation scores.

• Abstracts should not exceed 2500 characters. Title, authors, affiliations, references and spaces are not included in the character limit.

• Abstracts can only be submitted by bachelor’s or master’s degree students. All original research works must have a scientific supervisor.

• Abstracts must include authors and their affiliations (department, institution/hospital, city, state (if applicable), country). All information (title, author names, affiliations and abstract text) must be entered using the standard Latin alphabet without national diacritical marks (e.g., ą, č, ę, ė, į, š, ų, ū, ž should be written as a, c, e, e, i, s, u, u, z), as it will appear in the Abstract book.

Abstracts must include the following parts

• Introduction – key information to introduce the background of your research and illustrate its scientific problem;

• Aim – a short description of research objectives;

• Methods – a description of methods and materials used in the research, including type of study and statistical methods;

• Results – a description of the obtained results;

• Conclusions – a summary of your research and answers to the objectives. Try to avoid phrases such as “scientific research is in progress”, “the results and conclusions will be presented at the conference”;

• References – a list of literature sources that were used during your study. Sources for the abstract must not be older than 10 years. Citations should be written in Vancouver Citation Style.

Evaluation

Each abstract will be evaluated independently by 2 or 3 IHSC 2027 Reviewers according to a set of evaluation criteria. Each criterion is scored, and based on the total score, the abstract is either accepted and allocated to a session or rejected. There will be no secondary review: the decision (accepted or rejected) is final and is based on the abstract as submitted. Reviewers may leave comments, which will be available to the authors in the submission system together with the final decision. Authors of accepted abstracts may revise their abstract according to the Reviewers’ comments before uploading the presentation or poster (to be announced). Revisions must be limited to addressing the Reviewers’ comments; the title, authors, study data and main conclusions cannot be changed. Revised abstracts are not re-evaluated, and the revised version will be published in the Abstract book. The main evaluation areas are listed below; each area consists of more detailed criteria:

• Scientific relevance and originality of the research

• Clarity of the research aim

• Appropriateness of the study design and methodology

• Quality and presentation of the results

• Validity of the interpretation and conclusions

• Structure, clarity and compliance with the abstract requirements

Other terms

• Each author will be asked to read and sign the statement of authorship as well as declare there was no conflict of interest during the making of the abstract when submitting an abstract.

• Literature reviews (including systematic review and meta-analysis review) are NOT accepted.

• Bioethical permission – see the “Bioethics” section below.

• Abstracts must not have been published in any format before submitting the abstract (e.g., the Abstract book).

• The final version of the accepted abstract (the submitted version or the version revised according to the Reviewers’ comments) will be published in the Abstract book without further editing by the Organising Committee. The IHSC 2027 Organising Committee will not be responsible for any errors in the abstracts.

• Depending on the number of accepted abstracts in each session, the Organising Committee reserves the right to transfer an abstract to a different session or to combine sessions.

• Only abstracts that comply with the terms and requirements will be published in the Abstract book.

• By uploading abstracts, participants agree to the Terms for registering and accepting abstracts.

Terms for registering and accepting abstracts

• Case report must be written in English.

• One submitter can submit only one case report abstract.

• Case report can be submitted only for oral presentation.

• Case report should not exceed 2000 characters. Title, authors, affiliations, references and spaces are not included in the character limit.

• Case report can only be submitted by bachelor’s or master’s degree students. All case report works must have a scientific supervisor.

• All case reports need the authorisation of the head of the clinic from which the case was taken. When submitting, enter the clinic and its head in the submission system; the head of the clinic confirms the authorisation by e-mail.

• Case report must include authors and their affiliations (department, institution/hospital, city, state (if applicable), country). All information (title, author names, affiliations and abstract text) must be entered using the standard Latin alphabet without national diacritical marks (e.g., ą, č, ę, ė, į, š, ų, ū, ž should be written as a, c, e, e, i, s, u, u, z), as it will appear in the Abstract book.

Case report must include the following parts

• Introduction – key information to introduce the background of your case report;

• Case presentation – history, physical exam, diagnostics, treatment/management, clinical course/outcome;

• Discussion – epidemiology, pathophysiology, clinical presentation, diagnosis, treatment/management, prognosis/prevention;

• Conclusions – a summary of your case report;

• References – a list of literature sources that were used in your abstract. Sources for the abstract must not be older than 10 years. Citations should be written in Vancouver Citation Style.

Evaluation

Each case report will be evaluated independently by 2 or 3 IHSC 2027 Reviewers according to a set of evaluation criteria. Each criterion is scored, and based on the total score, the case report is either accepted and allocated to a session or rejected. There will be no secondary review: the decision (accepted or rejected) is final and is based on the case report as submitted. Reviewers may leave comments, which will be available to the authors in the submission system together with the final decision. Authors of accepted case reports may revise their case report according to the Reviewers’ comments before uploading the presentation (to be announced). Revisions must be limited to addressing the Reviewers’ comments; the title, authors, clinical data and main conclusions cannot be changed. Revised case reports are not re-evaluated, and the revised version will be published in the Abstract book. The main evaluation areas are listed below; each area consists of more detailed criteria:

• Clinical relevance and educational value of the case

• Originality and contribution of the case

• Quality of the case presentation

• Diagnostic reasoning and management

• Discussion and conclusions

• Structure, clarity and compliance with the case report requirements

Other terms

• Each author will be asked to read and sign the statement of authorship as well as declare there was no conflict of interest during the making of the case report abstract when submitting an abstract.

• Case report abstract must not have been published in any format before (e.g., the Abstract book).

• The final version of the accepted case report (the submitted version or the version revised according to the Reviewers’ comments) will be published in the Abstract book without further editing by the Organising Committee. The IHSC 2027 Organising Committee will not be responsible for any errors in the case reports.

• Only case report abstracts that comply with the terms and requirements will be published in the Abstract book.

• By uploading abstracts, participants agree to the Terms for registering and accepting abstracts.

• The presentations should be prepared in English.

• Presentations should be prepared using Microsoft Office PowerPoint. Presenters take full responsibility for file formats and the quality of the presentation.

• The oral presentation should last no longer than 7 minutes, followed by a 2-minute discussion and questions.

• Only the active participant can be a presenter. The presenter must participate in the discussion after the presentation. Co-authors may also take part in the discussion.

• Presenters will be asked to use the official IHSC 2027 presentation template for their presentation. The template will be sent with the Reviewers’ final decision by the 5th of February 2027.

• Oral presentations must be uploaded to the online MS Forms which is sent by the Organising Committee: to be announced.

• If the provided template is not used, the Organising Committee reserves the right to decline presentation at the conference and not to publish the abstract in the abstract book.

• Presentations will be evaluated by a professional Jury Committee during the conference.

• All posters will be presented on-site during the Poster session.

• All posters will be presented digitally on-screen and will be presented by the active participant (presenter). The presenter must participate in the discussion after the presentation. Co-authors may also take part in the discussion.

• Microsoft Office PowerPoint slides cannot be used in the presentation.

• Posters should follow the requirements specified in the Abstract requirements and be presented using the given template.

• If the provided template is not used, the Organising Committee reserves the right to decline presentation at the conference and not to publish the work in the abstract book.

• Templates will be sent with the final Reviewers’ decision by the 5th of February 2027.

• A poster is NOT equivalent to an abstract presentation. A poster should illustrate the main points of focus of the abstract using the provided official IHSC 2027 template.

• The presentation should last no longer than 5 minutes, followed by a 2-minute discussion and questions.

• Posters and their presentations will be evaluated by a professional Jury Committee during the conference.

• The presentations should be prepared in English.

• Presentations should be prepared using Microsoft Office PowerPoint. Presenters take full responsibility for file formats and the quality of the presentation.

• The oral presentation should last no longer than 3 minutes, followed by a 2-minute discussion and questions.

• Only the active participant can be a presenter. The presenter must participate in the discussion after the presentation. Co-authors may also take part in the discussion.

• Authors will be asked to use the official IHSC 2027 presentation template for their presentation. The template will be sent with the Reviewers’ final decision by the 5th of February 2027.

• Oral presentations must be uploaded to the online MS Forms which is sent by the Organising Committee: to be announced.

• If the provided template is not used, the Organising Committee reserves the right to decline presentation at the conference and not to publish the abstract in the abstract book.

• Presentations will be evaluated by a professional Jury Committee during the conference.

We recommend all abstracts to have a permission issued by the biomedical research ethical committee. If an abstract does not have such permission, we require the authors to provide an explanation.

Permission details must be provided in the submission system while submitting the abstract.

All abstracts submitted without permission will be reviewed by biomedical research ethical experts to determine if the research needs approval.

Case reports need the authorisation of the head of the clinic from which the case was taken: enter the clinic and its head in the submission system together with the case report; the head of the clinic confirms by e-mail.

The Organising Committee reserves the right to reject an abstract if it is determined that research was conducted without necessary permissions.